Celltrion
Celltrion is a leading biopharmaceutical company headquartered in Incheon, South Korea. It specializes in research, development and manufacturing of innovative therapeutics to improve people's lives worldwide. Celltrion is committed to delivering affordable and accessible advanced therapies, with a focus on next-generation biologics and small molecule products. Industries it has a preference for include: diversified/conglomerates, biotechnology, healthcare, information technology, pharmaceuticals. It's preferred route(s) to market include: primary funds, secondary funds.